{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:12:08Z","timestamp":1761487928320,"version":"3.33.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.neuropharm.2007.09.006","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T15:00:58Z","timestamp":1191337258000},"page":"951-957","source":"Crossref","is-referenced-by-count":31,"title":["The effects of lamotrigine on alcohol seeking and relapse"],"prefix":"10.1016","volume":"53","author":[{"given":"Valentina","family":"Vengeliene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian A.","family":"Heidbreder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Spanagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.09.006_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2004.09.016","article-title":"Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats","volume":"1029","author":"Ahmad","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.bjp.0705737","article-title":"Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat","volume":"142","author":"Ahmad","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.npp.1300657","article-title":"The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behaviour in rat","volume":"30","author":"Bachteler","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.ALC.0000122101.13164.21","article-title":"Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behaviour","volume":"28","author":"B\u00e4ckstr\u00f6m","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1472-8206.2005.00380.x","article-title":"Lamotrigine pharmacokinetic\/pharmacodynamic modelling in rats","volume":"19","author":"Castel-Branco","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0893-133X(02)00302-0","article-title":"Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behaviour by drug-associated stimuli in rats","volume":"27","author":"Ciccocioppo","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/13556210500314550","article-title":"Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?","volume":"10","author":"Egli","year":"2005","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0893-133X(97)00130-9","article-title":"Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats","volume":"18","author":"Heyser","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib9","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(96)00670-X","article-title":"Evidence for alcohol anti-craving properties of memantine","volume":"314","author":"H\u00f6lter","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-3565(24)35324-8","article-title":"The non-competitive NMDA receptor antagonist MRZ 2\/579 suppresses the alcohol deprivation effect in long-term alcohol drinking rats and substitutes the alcohol cue in a discrimination task","volume":"292","author":"H\u00f6lter","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib11","first-page":"41","article-title":"Long-term ethanol self-administration with repeated withdrawal episodes changes ethanol drinking pattern and increases anxiety during withdrawal in rats","volume":"9","author":"H\u00f6lter","year":"1998","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib12","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1517\/14656566.5.9.1943","article-title":"An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence","volume":"5","author":"Johnson","year":"2004","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib13","series-title":"Drugs for Relapse Prevention of Alcoholism","first-page":"107","article-title":"Serotonergic compounds: clinical data","author":"Johnson","year":"2005"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.61.9.905","article-title":"Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial","volume":"61","author":"Johnson","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.neuron.2005.02.005","article-title":"Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission","volume":"45","author":"Kalivas","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0269881105051542","article-title":"Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?","volume":"19","author":"Kalyoncu","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1530-0277.2007.00344.x","article-title":"Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam","volume":"31","author":"Krupitsky","year":"2007","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0163-7258(03)00054-8","article-title":"N-methyl-d-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability","volume":"99","author":"Krystal","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib20","series-title":"Drugs for Relapse Prevention of Alcoholism","first-page":"95","article-title":"Serotonergic compounds: preclinical data","author":"L\u00ea","year":"2005"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0893-133X(99)00024-X","article-title":"Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol-seeking induced by priming injections of alcohol and exposure to stress","volume":"21","author":"Le","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0006-8993(93)91660-K","article-title":"Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamactil) using primary neurological cultures from rat cortex","volume":"612","author":"Lees","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/jpet.300.3.882","article-title":"Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats","volume":"300","author":"Liu","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib24","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1080\/10550490150504100","article-title":"Update on anticonvulsants for the treatment of alcohol withdrawal","volume":"10","author":"Malcolm","year":"2001","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/00952999809001700","article-title":"A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients","volume":"24","author":"Margolin","year":"1998","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/10550490500419110","article-title":"A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal","volume":"15","author":"Mariani","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib47","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1528-1157.1995.tb06002.x","article-title":"Lamotrigine","volume":"36","author":"Messenheimer","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1530-0277.2006.00299.x","article-title":"A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm","volume":"31","author":"Myrick","year":"2007","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1369-1600.2006.00033.x","article-title":"Modulation of high alcohol drinking in the inbred fawn-hooded (FH\/Wjd) rat strain: implications for treatment","volume":"11","author":"Overstreet","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1369-1600.2007.00061.x","article-title":"New developments in the pharmacotherapy of cocaine abuse","volume":"12","author":"Petri","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0741-8329(00)00083-5","article-title":"Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats","volume":"21","author":"Rodd-Henricks","year":"2000","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-5618.2006.00292.x","article-title":"Effects of lamotrigine in patients with bipolar disorder and alcohol dependence","volume":"8","author":"Rubio","year":"2006","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2004-815473","article-title":"Effects of topiramate in the treatment of alcohol dependence","volume":"37","author":"Rubio","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1530-0277.1986.tb05120.x","article-title":"Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats","volume":"10","author":"Samson","year":"1986","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","article-title":"Behavioural assessment of drug-reinforcement and addictive features in rodents: an overview","volume":"11","author":"Sanchis-Segura","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm1163","article-title":"The circadian clock gene Period2 alters the glutamatergic system and thereby modulates alcohol consumption","volume":"11","author":"Spanagel","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(99)01447-2","article-title":"The dopamine hypothesis of reward: past and current status","volume":"22","author":"Spanagel","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0165-6147(97)89800-8","article-title":"Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes","volume":"18","author":"Spanagel","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.49.1.173","article-title":"The role of glutamatergic neurotransmission in the pathophysiology of alcoholism","volume":"49","author":"Tsai","year":"1998","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuropharm.2005.01.002","article-title":"The role of the\u00a0NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect","volume":"48","author":"Vengeliene","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib41","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1096\/fj.06-6110com","article-title":"The D3 receptor plays an essential role in alcohol craving and relapse","volume":"20","author":"Vengeliene","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib42","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/00001756-200107200-00042","article-title":"Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity","volume":"12","author":"Wang","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib43","series-title":"Drugs for Relapse Prevention of Alcoholism","first-page":"135","article-title":"Dopaminergic compounds: preclinical data","author":"Weiss","year":"2005"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coph.2004.11.001","article-title":"Neurobiology of craving, conditioned reward and relapse","volume":"5","author":"Weiss","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.09.006_bib45","series-title":"Drugs for Relapse Prevention of Alcoholism","first-page":"155","article-title":"Dopaminergic compounds: clinical data","author":"Wiesbeck","year":"2005"},{"key":"10.1016\/j.neuropharm.2007.09.006_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF00373920","article-title":"Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones","volume":"430","author":"Xie","year":"1995","journal-title":"Pfl\u00fcgers Arch."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807002924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807002924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T10:43:03Z","timestamp":1737456183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807002924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0028390807002924"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.09.006","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}